Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database

被引:28
作者
Wei, Shenhai [1 ]
Tian, Jintao [1 ]
Song, Xiaoping [1 ]
Wu, Bingqun [1 ]
Liu, Limin [2 ]
机构
[1] Tsinghua Univ, Dept Thorac Surg, Hosp 1, Beijing 100016, Peoples R China
[2] Capital Med Univ, Dept Physiol, Beijing 100069, Peoples R China
关键词
Non-small cell lung cancer; Cause of death; Overall survival; Lung cancer-specific survival; PRIMARY MALIGNANCIES; SURVIVAL; STAGE; LOBECTOMY; TIME; PNEUMONECTOMY; COMORBIDITY; DIAGNOSIS; PROGNOSIS; RESECTION;
D O I
10.1007/s00432-017-2522-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To investigate the probability of death (POD) from any causes by time after diagnosis of non-small cell lung cancer (NSCLC) and the factors associated with survival for NSCLC patients. A total of 202,914 patients with NSCLC from 2004 to 2013 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. The overall survival (OS) and lung cancer-specific survival (LCSS) were calculated and POD from any causes at different time periods after diagnosis was explored. The predictive factors for OS, LCSS and survival from non-lung cancer deaths were investigated using multivariate analysis with Cox proportional hazards regression and competing risk regression analysis. The 5- and 10-year OS were 20.4% and 11.5%, accordingly that for LCSS were 25.5% and 18.4%, respectively. Lung cancer contributed 88.3% (n = 128,402) of the deaths. The POD from lung cancer decreased with time after diagnosis. In multivariate analysis, advanced age and advanced stage of NSCLC were associated with decreased OS and LCSS. Comparing to no surgery, any kind of resection conferred lower risk of death from lung cancer and higher risk of dying from non-lung cancer conditions except lobectomy or bilobectomy, which was associated with lower risk of death from both lung cancer and non-lung cancer conditions. Most of the patients with NSCLC died from lung cancer. Rational surveillance and treatment policies should be made for them. Early stage and lobectomy or bilobectomy were associated with improved OS and LCSS. It is reasonable to focus on early detection and optimal surgical treatment for NSCLC.
引用
收藏
页码:145 / 155
页数:11
相关论文
共 33 条
  • [1] Multiple independent primary cancers do not adversely affect survival of the lung cancer patient
    Aguilo, Rafael
    Macia, Francesc
    Porta, Miquel
    Casamitjana, Montserrat
    Minguella, Joan
    Novoa, Ana Maria
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2008, 34 (05) : 1075 - 1080
  • [2] Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival
    Alexiou, C
    Beggs, D
    Onyeaka, P
    Kotidis, K
    Ghosh, S
    Beggs, L
    Hopkinson, DN
    Duffy, JP
    Morgan, WE
    Rocco, G
    [J]. ANNALS OF THORACIC SURGERY, 2003, 76 (04) : 1023 - 1028
  • [3] Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non-Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10
    Butts, Charles A.
    Ding, Keyue
    Seymour, Lesley
    Twumasi-Ankrah, Philip
    Graham, Barbara
    Gandara, David
    Johnson, David H.
    Kesler, Kenneth A.
    Green, Mark
    Vincent, Mark
    Cormier, Yvon
    Goss, Glenwood
    Findlay, Brian
    Johnston, Michael
    Tsao, Ming-Sound
    Shepherd, Frances A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 29 - 34
  • [4] Cancer Statistics in China, 2015
    Chen, Wanqing
    Zheng, Rongshou
    Baade, Peter D.
    Zhang, Siwei
    Zeng, Hongmei
    Bray, Freddie
    Jemal, Ahmedin
    Yu, Xue Qin
    He, Jie
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) : 115 - 132
  • [5] Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics
    Colzani, Edoardo
    Liljegren, Annelie
    Johansson, Anna L. V.
    Adolfsson, Jan
    Hellborg, Henrik
    Hall, Per F. L.
    Czene, Kamila
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) : 4014 - 4021
  • [6] Risk of Second Primary Malignancies Among Cancer Survivors in the United States, 1992 Through 2008
    Donin, Nicholas
    Filson, Christopher
    Drakaki, Alexandra
    Tan, Hung-Jui
    Castillo, Alex
    Kwan, Lorna
    Litwin, Mark
    Chamie, Karim
    [J]. CANCER, 2016, 122 (19) : 3075 - 3086
  • [7] Second primary tumors involving non-small cell lung cancer - Prevalence and its influence on survival
    Duchateau, CSJ
    Stokkel, MPM
    [J]. CHEST, 2005, 127 (04) : 1152 - 1158
  • [8] Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis
    Eguchi, Takashi
    Bains, Sarina
    Lee, Ming-Ching
    Tan, Kay See
    Hristov, Boris
    Buitrago, Daniel H.
    Bains, Manjit S.
    Downey, Robert J.
    Huang, James
    Isbell, James M.
    Park, Bernard J.
    Rusch, Valerie W.
    Jones, David R.
    Adusumilli, Prasad S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (03) : 281 - +
  • [9] A proportional hazards model for the subdistribution of a competing risk
    Fine, JP
    Gray, RJ
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) : 496 - 509
  • [10] Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer
    Groth, Shawn S.
    Rueth, Natasha M.
    Hodges, James S.
    Habermann, Elizabeth B.
    Andrade, Rafael S.
    D'Cunha, Jonathan
    Maddaus, Michael A.
    [J]. ANNALS OF THORACIC SURGERY, 2010, 90 (02) : 375 - 382